Shanghai Hile Bio-Technology Co., Ltd. (603718.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.96B
Enterprise Value3.76B
P/E Ratio-5.75
PEG Ratio0.02
Price/Sales Ratio10.75
Price/Book Ratio2.04
Enterprise/Revenue10.52
Enterprise/EBITDA-10.23

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-1.82
Operating Margin0.2
AD

Management Effectiveness

Return On Assets-0.25
Return On Equity-0.26

Income Statement

Revenue187.87M
Revenue/Share0.27
Gross Profit135.59M
EBITDA-165.67M
Net Income-311.44M
Diluted EPS-0.48

Balance Sheet

Total Cash387.72M
Total Cash/Share0.61
Total Debt88.21M
Total Debt/Equity0.1
Current Ratio4.27
Book Value Per Share1.48

Price History

52-Week Change-62.57
52-Week High7.81
52-Week Low2.57
Moving Average 50 Days3.01
Moving Average 200 Days4.9

Statistics

Average Volume11.87M
Shares Outstanding651.9M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield2.74
Payout Ratio-0.22
Last Split Factor23:10
Last Split DateMay 05, 2016
AD